The U.S. Department of Health and Human Services’ Office of Inspector General (OIG) recently issued a favorable Advisory Opinion (No. 26-14) to a pharmaceutical manufacturer that is proposing to offer free antibody testing to patients.
In the proposed arrangement, the manufacturer would offer free antibody testing to determine whether patients would qualify for a prescribed
